BiomX Inc. (PHGE) Financial Statements (2024 and earlier)

Company Profile

Business Address 22 EINSTEIN ST., 4TH FLOOR
NESS ZIONA, 7414003
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
6/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14,90733,33262,09956,32882,259697
Cash and cash equivalents14,90731,33262,09936,47772,256697
Short-term investments  2,000 19,85110,003 
Restricted cash and investments  996 154 
Receivables  567888 50 
Prepaid expense      40
Other current assets1,7682,5873,5433,5762,068 
Other undisclosed current assets 957395(888)763  
Total current assets:17,63236,88166,63860,66784,531736
Noncurrent Assets
Operating lease, right-of-use asset3,4953,8604,1394,4301,148
Property, plant and equipment3,9024,7905,6942,2281,881 
Long-term investments and receivables      70,881
Long-term investments      70,881
Intangible assets, net (including goodwill)  1,519   
Goodwill      
Intangible assets, net (excluding goodwill)   1,519   
Deposits noncurrent assets     5 
Other undisclosed noncurrent assets    3,0384,5561
Total noncurrent assets:7,3978,65011,3529,6967,59070,882
TOTAL ASSETS:25,02945,53177,99070,36392,12171,619
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,7251,2562,7952,3203,253136
Taxes payable   136
Accounts payable4,7258202,7952,3203,253 
Accrued liabilities  436    
Deferred revenue   1,976  
Debt 5,785687819863375 
Other liabilities   5,4533,9782,596 
Other undisclosed current liabilities6665,996   235
Total current liabilities:11,1767,93911,0437,1616,224371
Noncurrent Liabilities
Long-term debt and lease obligation, including: 5,40210,59119,1975,032856 
Long-term debt, excluding current maturities 5,40210,59114,410   
Other undisclosed long-term debt and lease obligation    5,032856 
Liabilities, other than long-term debt5,3705,962215701585500
Deferred revenue1,9761,976   
Due to related parties    500
Other liabilities155188215   
Operating lease, liability3,2393,7984,787  
Business combination, contingent consideration, liability    701585 
Other undisclosed noncurrent liabilities      
Total noncurrent liabilities:10,77216,55319,4125,7331,441500
Total liabilities:21,94824,49230,45512,8947,665871
Temporary equity, carrying amount     65,748
Equity
Equity, attributable to parent3,08121,03947,53557,46984,4565,000
Common stock322220
Additional paid in capital166,048157,838156,017129,725126,6264,653
Accumulated other comprehensive loss  (136,801)(108,484)(72,258)(42,172) 
Retained earnings (accumulated deficit)(162,970)    346
Total equity:3,08121,03947,53557,46984,4565,000
TOTAL LIABILITIES AND EQUITY:25,02945,53177,99070,36392,12171,619

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
6/30/2019
Revenues35759886641921 
Net investment income  46486641921 
Other income357134    
Cost of revenue
(Cost of Goods and Services Sold)
    (10)  
Gross profit:35759886631921 
Operating expenses(25,348)(376)(33,943)(30,258)(22,207)(405)
Other operating expense, net
(Other Expenses)
  (160)    
Other undisclosed operating loss(357)(27,281)(1,605)(631)(921) 
Operating loss:(25,348)(27,219)(35,462)(30,258)(22,207)(405)
Nonoperating income (expense)1,24990221721,644 
Investment income, nonoperating  21721,644 
Other nonoperating income (expense)1,249902    
Interest and debt expense(2,404)(2,069)(983)   
Other undisclosed income from continuing operations before equity method investments, income taxes      887
Income (loss) from continuing operations before equity method investments, income taxes:(26,503)(28,386)(36,443)(30,086)(20,563)483
Other undisclosed income (loss) from continuing operations before income taxes357134    
Income (loss) from continuing operations before income taxes:(26,146)(28,252)(36,443)(30,086)(20,563)483
Income tax expense(23)(65)(67) (2,308)(135)
Income (loss) from continuing operations:(26,169)(28,317)(36,510)(30,086)(22,871)347
Income (loss) before gain (loss) on sale of properties:(36,510)(30,086)(22,871)347
Other undisclosed net income   284 2,308 
Net income (loss) attributable to parent:(26,169)(28,317)(36,226)(30,086)(20,563)347
Other undisclosed net income available to common stockholders, basic     41,126 
Net income (loss) available to common stockholders, diluted:(26,169)(28,317)(36,226)(30,086)20,563347

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
6/30/2019
Net income (loss):(26,169)(28,317)(36,226)(30,086)(20,563)347
Comprehensive income (loss), net of tax, attributable to parent:(26,169)(28,317)(36,226)(30,086)(20,563)347

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: